C-aryl glucoside SGLT2 inhibitors and method for their production

Details for Australian Patent Application No. 2005286608 (hide)

Owner Bristol-Myers Squibb Company

Inventors Washburn, William; Meng, Wei

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005286608

PCT Pub. Number WO2006/034489

Priority 60/612,599 23.09.04 US

Filing date 23 September 2005

Wipo publication date 30 March 2006

International Classifications

C07H 7/04 (2006.01) Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond

A61K 31/70 (2006.01) - Carbohydrates

C07H 15/04 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034489 Priority application(s): WO2006/034489

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286621-Method for forming packaging blanks from plastic sheet

2005286607-Cysteine engineered antibodies and conjugates